Home » New Partnership Between GSK and the Gates Foundation to Speed Research Into Vaccines
New Partnership Between GSK and the Gates Foundation to Speed Research Into Vaccines
GlaxoSmithKline and the Bill & Melinda Gates Foundation have put $1.8 million into a new joint venture that will attempt to make vaccines more resistant to heat.
World Pharma News
World Pharma News
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May